Glucose metabolism is central to regulation of ?-cell function and survival. We have found that phosphorylation of the BCL-2 family protein BAD within its helical BH3 domain imparts cell autonomous protective effects to ?-cells. The benefits of genetic and pharmacologic strategies that mimic the phospho-BAD BH3 helix include resistance to death induced by inflammatory and oxidative stress, as well as increased glucose handling and insulin secretory capacities. In the long-term, these benefits manifest in superior engraftment of donor islets in transplanted diabetic mice and an attendant increase in functional ?-cell mass. The ?-cell protective effect of phospho-BAD is dependent on the glucose-metabolizing enzyme glucokinase (GK), and is mediated by direct binding and activation of this enzyme by the phospho-BAD BH3 helix. Our proposed studies address a key question that stems from these findings: How is the ?-cell sparing effect of phospho-BAD mediated by GK-dependent glucose metabolism? We will address this question at two highly integrative molecular layers. First, using metabolic flux analyses we will identify phospho-BAD dependent changes in mitochondrial metabolism of glucose-derived pyruvate at the level of pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC) pathway fluxes as ?-cells are subjected to defined stress stimuli, and define their contribution to phospho-BAD's capacity to shield ?-cells from stress-induced dysfunction and death (aim 1). Second, we will interrogate a defined number of MODY-derived GK mutants for their in vitro properties as well as their effect on ?-cell survival in the presence of phospho-BAD (aim 2). These mutants, which are selected for their proximity near the binding interface of the BAD BH3 helix on GK, will reveal additional molecular aspects of GK regulation by phospho-BAD mimicry and provide a complementary experimental system to examine the effect of GK-dependent glucose metabolism on the ?-cell protective effect of BAD phosphorylation. These studies will provide an integrated picture of the pathway connecting phospho-BAD-dependent GK activation and ?-cell resistance to stress-induced dysfunction and death. In the fullness of time, understanding this pathway will yield valuable translational insights into the most effective strategies to capture and mimic the protective aspects of glucose signaling for preservation/restoration of functional ?-cell mass.

Public Health Relevance

Strategies that can simultaneously improve the function and survival of pancreatic ?-cells, which produce all of the insulin needed for the body, may be effective against ?-cell dysfunction in diabetes. The studies proposed in this application will characterize the molecular properties of a protein called BAD that can simultaneously regulate ?-cell function and survival, with the ultimate goal of translating this understanding into new effective therapies for diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK078081-09
Application #
9662817
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Sato, Sheryl M
Project Start
2007-04-01
Project End
2021-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Ljubicic, Sanda; Polak, Klaudia; Fu, Accalia et al. (2015) Phospho-BAD BH3 mimicry protects ? cells and restores functional ? cell mass in diabetes. Cell Rep 10:497-504
Giménez-Cassina, Alfredo; Danial, Nika N (2015) Regulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins. Trends Endocrinol Metab 26:165-75
Lo, James C; Ljubicic, Sanda; Leibiger, Barbara et al. (2014) Adipsin is an adipokine that improves ? cell function in diabetes. Cell 158:41-53
Giménez-Cassina, Alfredo; Garcia-Haro, Luisa; Choi, Cheol Soo et al. (2014) Regulation of hepatic energy metabolism and gluconeogenesis by BAD. Cell Metab 19:272-84
Szlyk, Benjamin; Braun, Craig R; Ljubicic, Sanda et al. (2014) A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators. Nat Struct Mol Biol 21:36-42
Fu, Suneng; Fan, Jason; Blanco, Joshua et al. (2012) Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting. PLoS Genet 8:e1002902
Osundiji, Mayowa A; Godes, Marina L; Evans, Mark L et al. (2011) BAD modulates counterregulatory responses to hypoglycemia and protective glucoprivic feeding. PLoS One 6:e28016
Tinoco, Arthur D; Kim, Yun-Gon; Tagore, Debarati M et al. (2011) A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones. Biochemistry 50:2213-22